Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announces that Christopher Bath has been appointed Chief Executive Officer (CEO) effective 1st January 2022. Chris will be responsible for a business with a portfolio of market leading medicinal products ...
Lausanne, Switzerland (ots) - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly ...
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the ...
London (ots/PRNewswire) - - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to ...
Bologna, Italy and Huntingdon Valley, Pa. (ots/PRNewswire) - Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating ...
The Hague, The Netherlands (ots/PRNewswire) - - Big Data analyses have produced novel insights that may improve the prognostication of patients with AML and CLL - These results may be used to identify high-risk patients and to make better-informed treatment choices in the future - The new data is presented at the ...
HERZLIYA, Israel (ots/PRNewswire) - 2021 Acceleration Comes in the Face of Global Components Shortages Essence Group, a leading technology group developing IoT-based security, safety and healthcare solutions for homes, families and businesses, today announced that it has, since its foundation, deployed over 75 ...
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
Basel (ots) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with diabetes in Europe [1] - ...
The International Osteoporosis Foundation (IOF)
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...
Lausanne, Switzerland (ots) - - Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin’s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease1 - Naratuximab ...
Basel (ots) - ● Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. ● Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. ● By collaborating with Lilly, ...
Geneva (ots) - FDI World Dental Federation (FDI) today launched a new initiative, with commitments from four founding industry partners – Colgate, Dentsply-Sirona, GSK Consumer Healthcare, and TePe – to lead the charge on sustainability in dentistry. Over the next two years FDI will work collaboratively with its ...
Lausanne, Switzerland (ots) - - Currently approved COVID-19 vaccines based on messenger RNA (mRNA) technology require two injections, given several weeks apart, for optimal protection against the virus - Debiopharm has launched a vaccine innovation challenge to a pool of international “problem Solvers” within ...
Basel (ots) - Innovative digital health solutions are enlarging treatment and diagnostic possibilities in telemedicine. Patients in Switzerland can now have their cough analyzed via an app on their smartphone. The results support doctors in advising and treating their patients. As the first European partner of ResApp, Medgate is integrating the acute respiratory diagnostic test ResAppDx into the Medgate app in a pilot ...
Hitachi Medical Systems Europe Holding AG
Lausanne, Switzerland and Seongnam-si Gyeonggi-do, Republic of Korea (ots) - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading ...
Geneva, Switzerland (ots) - Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today called for more countries to enable dentists to administer COVID-19 vaccines after a survey of its members revealed the small ...
European Society for Medical Oncology (ESMO)
ST. GALLEN, Switzerland (ots) - ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results. The test can be administered by trained professionals and doesn’t rely on laboratory-processing. Approved by Swissmedic, ...
Basel (ots) - - The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes(1). - By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche's strategy of integrated Personalised Diabetes Management (iPDM). Roche ...